21 CFR 812 - Investigational
Device Exemptions
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/showCFR.cfm?CFRPart=812
21 CFR 50 - Protection of Human
Subjects
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/showCFR.cfm?CFRPart=50
21 CFR 56 - Institutional Review
Boards
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/showCFR.cfm?CFRPart=56
21 CFR 54 - Financial Disclosure
by Clinical Investigators
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/showCFR.cfm?CFRPart=54
21 CFR 58 - Good Laboratory Practice
for Nonclinical Laboratory Studies
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/showCFR.cfm?CFRPart=58
21 CFR 820 - Quality System Regulation
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/showCFR.cfm?CFRPart=820
Last modified date 01/02/2002